"Uric Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
MeSH Number(s)
D03.132.960.877
D03.438.759.758.824.877
Concept/Terms
Uric Acid- Uric Acid
- Acid, Uric
- Trioxopurine
- 2,6,8-Trihydroxypurine
Sodium Urate Monohydrate- Sodium Urate Monohydrate
- Monohydrate, Sodium Urate
- Urate Monohydrate, Sodium
- Monosodium Urate Monohydrate
- Monohydrate, Monosodium Urate
- Urate Monohydrate, Monosodium
- Sodium Acid Urate Monohydrate
- Sodium Urate
- Urate, Sodium
- Monosodium Urate
- Urate, Monosodium
- Sodium Acid Urate
- Acid Urate, Sodium
- Urate, Sodium Acid
Below are MeSH descriptors whose meaning is more general than "Uric Acid".
Below are MeSH descriptors whose meaning is more specific than "Uric Acid".
This graph shows the total number of publications written about "Uric Acid" by people in Harvard Catalyst Profiles by year, and whether "Uric Acid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 2 | 1 | 3 |
1996 | 1 | 1 | 2 |
1997 | 1 | 2 | 3 |
1998 | 1 | 1 | 2 |
1999 | 1 | 0 | 1 |
2000 | 2 | 0 | 2 |
2001 | 2 | 3 | 5 |
2002 | 1 | 0 | 1 |
2003 | 2 | 2 | 4 |
2004 | 5 | 3 | 8 |
2005 | 4 | 2 | 6 |
2006 | 6 | 1 | 7 |
2007 | 6 | 6 | 12 |
2008 | 14 | 5 | 19 |
2009 | 9 | 2 | 11 |
2010 | 12 | 6 | 18 |
2011 | 10 | 1 | 11 |
2012 | 15 | 11 | 26 |
2013 | 9 | 6 | 15 |
2014 | 18 | 11 | 29 |
2015 | 11 | 3 | 14 |
2016 | 13 | 7 | 20 |
2017 | 16 | 11 | 27 |
2018 | 13 | 6 | 19 |
2019 | 14 | 13 | 27 |
2020 | 11 | 16 | 27 |
2021 | 13 | 9 | 22 |
2022 | 5 | 20 | 25 |
2023 | 4 | 15 | 19 |
2024 | 1 | 2 | 3 |
Below are the most recent publications written about "Uric Acid" by people in Profiles.
-
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout. Rheumatology (Oxford). 2024 Apr 02; 63(4):1058-1067.
-
The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout. Nat Rev Rheumatol. 2024 Apr; 20(4):216-231.
-
Serum Urate and Recurrent Gout. JAMA. 2024 02 06; 331(5):417-424.
-
Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in Gout. Arthritis Rheumatol. 2024 Apr; 76(4):638-646.
-
Diagnostic performance and feasibility of dual-layer detector dual-energy CT for characterization of urinary stones in patients of different sizes. Abdom Radiol (NY). 2024 Jan; 49(1):209-219.
-
Pharmacologic treatment of kidney stones: Current medication and pH monitoring. Actas Urol Esp (Engl Ed). 2024 Jan-Feb; 48(1):11-18.
-
Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial. J Clin Hypertens (Greenwich). 2023 10; 25(10):915-922.
-
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study. Ann Intern Med. 2023 08; 176(8):1067-1080.
-
Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA). Eur J Med Res. 2023 Jul 17; 28(1):238.
-
Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population-Based, Prospective Study and Mendelian Randomization Analysis. Arthritis Rheumatol. 2023 09; 75(9):1648-1657.